R
R. Kessler
Publications - 2
Citations - 163
R. Kessler is an academic researcher. The author has contributed to research in topics: Lung cancer & Neutropenia. The author has an hindex of 2, co-authored 2 publications receiving 158 citations.
Papers
More filters
Journal ArticleDOI
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.
J.L. Pujol,J.-L. Breton,Radj Gervais,P. Rebattu,Alain Depierre,Jean-François Morère,B. Milleron,D. Debieuvre,D. Castera,P.J. Souquet,Denis Moro-Sibilot,Etienne Lemarié,R. Kessler,H. Janicot,D. Braun,D. Spaeth,Xavier Quantin,C. Clary +17 more
TL;DR: There was no advantage in PFS with GD compared with CV; however, the CV regimen had higher rate of toxic events, mainly myelosuppression, and the herein, non-platinum-containing regimen could be considered as a rational alternative to the cisplatin-based doublet.
Journal ArticleDOI
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study
E. Quoix,J.-L. Breton,C. Daniel,P. Jacoulet,Didier Debieuvre,N. Paillot,R. Kessler,L. Moreau,D. Coëtmeur,Etienne Lemarié,Bernard Milleron +10 more
TL;DR: The overall results suggest that patients even older than 70 years may benefit from full treatment, and consideration should be given to offering active treatment to most patients with SCLC, regardless of age but with special attention paid to comorbidities.